Klivira
Request demo

Navigating Anthem (Elevance Health) Trodelvy Prior Authorization

Klivira streamlines the complex process of Anthem (Elevance Health) Trodelvy prior authorization, integrating with your EMR to automate submissions and track status across diverse payer channels.

For revenue cycle directors and prior authorization coordinators, managing specialty drug PAs like Trodelvy with Anthem-licensed plans requires precise navigation of specific submission channels and clinical criteria. Understanding Elevance Health's operational framework is key to minimizing delays and denials.

Understanding Trodelvy Prior Authorization with Anthem

Trodelvy (sacituzumab govitecan-hziy) is a high-volume prior authorization target across Anthem's commercial, Medicare Advantage, and Medicaid managed care plans. Its status as a specialty medication necessitates adherence to specific medical policies, formulary guidelines, and site-of-care requirements established by Anthem operating companies and their partners.

Anthem Prior Authorization Submission Channels

Anthem-licensed plans utilize distinct channels for medical and pharmacy benefit prior authorizations. Medical benefit specialty injectables like Trodelvy are typically submitted through Availity Essentials, Anthem's primary multi-payer provider workspace. X12 278 transactions are accepted via clearinghouses for applicable procedures. For pharmacy benefit PAs, CarelonRx (Elevance Health's in-house PBM) processes retail PA through its provider system and via ePA partners like CoverMyMeds and Surescripts.

Accessing Anthem Medical Policies for Trodelvy

Anthem operating companies publish medical-policy and clinical-UM-guideline libraries through provider sites, accessible via Availity. Each state-licensed Anthem plan maintains its own medical-policy index, which aligns with the Elevance Health corporate criteria framework and includes state-specific Medicaid and Medicare Advantage variants. For specialty drugs, policies often detail specific clinical indications, step therapy requirements, and site-of-care criteria.

Common Denial Patterns and Appeal Pathways

Denials for Trodelvy prior authorizations from Anthem are returned via X12 277/835 transactions and Availity status updates. Common denial categories include medical necessity, insufficient documentation, step therapy not completed, site-of-service mismatch, or non-formulary status. Appeals for standard medical PAs route through the Anthem operating-company appeals process, with peer-to-peer reviews available.

Electronic Prior Authorization (ePA) Capabilities

Elevance Health, through its Anthem operating companies, has participated in Da Vinci Project initiatives. While specific production conformance for PAS, CRD, and DTR requires verification, Anthem does accept X12 278 transactions for medical benefit PAs. For pharmacy benefit, CarelonRx supports ePA submissions through CoverMyMeds and Surescripts, enhancing efficiency for prescriber-initiated workflows.

Prior Authorization Turnaround Times

Commercial PA timeframes for Anthem-licensed plans are governed by state insurance regulations, which vary materially across states. For Medicare Advantage, Medicaid managed care (including Wellpoint subsidiary), and QHP-on-FFM lines, Anthem is an impacted payer under CMS-0057-F. This rule mandates phased compliance with 72-hour standard and 24-hour expedited PA decision timeframes.

Frequently asked questions

How do I submit a prior authorization for Trodelvy with Anthem?

For Trodelvy, typically a medical benefit specialty injectable, prior authorizations are submitted through Availity Essentials, Anthem's primary multi-payer provider workspace. You can initiate the PA tool, lookup member benefits, and upload supporting documentation there. X12 278 transactions are also accepted via clearinghouses.

Where can I find the specific medical policy for Trodelvy for an Anthem plan?

Anthem operating companies publish their medical policies and clinical UM guidelines on provider sites, accessible through Availity. You'll need to reference the specific policy number, plan-state context, and effective date, as policies can vary by state and line of business (e.g., commercial, Medicare Advantage, Medicaid).

What are common reasons for Trodelvy PA denials from Anthem?

Common denial reasons include medical necessity not met, insufficient clinical documentation, failure to complete required step therapy, or issues with the proposed site-of-service. Denials are communicated via X12 277/835 transactions and Availity status updates.

Does Anthem support electronic prior authorization (ePA) for specialty drugs like Trodelvy?

Yes, Anthem accepts X12 278 transactions for medical benefit prior authorizations. For pharmacy benefit drugs, CarelonRx partners with CoverMyMeds and Surescripts for ePA submissions. Elevance Health has also participated in Da Vinci Project initiatives, indicating a commitment to advancing electronic standards.

What are the typical turnaround times for Trodelvy prior authorizations with Anthem?

Turnaround times vary. Commercial PA timeframes are dictated by state insurance regulations. For Medicare Advantage and Medicaid managed care plans, Anthem is subject to CMS-0057-F, which mandates phased compliance with 72-hour standard and 24-hour expedited decision timeframes.

Is Carelon Medical Benefits Management involved in Trodelvy PAs?

Carelon Medical Benefits Management (formerly AIM Specialty Health) primarily manages prior authorizations for advanced imaging, cardiology, MSK, sleep, and radiation oncology. While some specialty injectables may route through Carelon entities, the primary channel for medical benefit infusions like Trodelvy is typically through Availity, subject to Anthem's site-of-care and clinical-indication policies.

Related coverage

Other trodelvy prior authorization by payer

Other trodelvy prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo